CDC- BRFSS – ACBS 2024 Adult Prevalence Table 6
Updated October 27, 2025
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 330 | 20.3 | 3.8 | (12.9 – 27.7) |
| California | 272 | 38.7 | 5.1 | (28.7 – 48.7) |
| Connecticut | 306 | 34.7 | 3.7 | (27.4 – 42.0) |
| Florida | 370 | 33.4 | 5.3 | (23.0 – 43.8) |
| Georgia | 324 | 32.6 | 4.1 | (24.6 – 40.6) |
| Illinois | 344 | 33.2 | 3.2 | (26.9 – 39.5) |
| Indiana | 576 | 32.0 | 2.3 | (27.5 – 36.5) |
| Iowa | 265 | 34.0 | 4.1 | (26.0 – 42.0) |
| Kansas | 307 | 40.3 | 3.7 | (33.0 – 47.6) |
| Kentucky | 146 | 24.8 | 4.7 | (15.6 – 34.0) |
| Maine | 415 | 32.1 | 3.3 | (25.6 – 38.6) |
| Maryland | 642 | 34.1 | 2.9 | (28.4 – 39.8) |
| Massachusetts | 355 | 38.0 | 3.5 | (31.1 – 44.9) |
| Michigan | 506 | 33.9 | 3.3 | (27.4 – 40.4) |
| Minnesota | 658 | 26.1 | 2.2 | (21.8 – 30.4) |
| Missouri | 170 | 44.3 | 6.4 | (31.8 – 56.8) |
| Nebraska | 327 | 33.2 | 4.5 | (24.4 – 42.0) |
| New Hampshire | 334 | 26.2 | 3.7 | (18.9 – 33.5) |
| New Jersey | 384 | 27.6 | 3.1 | (21.5 – 33.7) |
| New York | 827 | 30.7 | 2.5 | (25.8 – 35.6) |
| Ohio | 373 | 33.2 | 3.7 | (25.9 – 40.5) |
| Oregon | 203 | 31.4 | 3.9 | (23.8 – 39.0) |
| Rhode Island | 238 | 25.9 | 3.9 | (18.3 – 33.5) |
| Texas | 219 | 29.9 | 4.7 | (20.7 – 39.1) |
| Utah | 486 | 28.0 | 2.8 | (22.5 – 33.5) |
| Vermont | 311 | 35.8 | 3.6 | (28.7 – 42.9) |
| Wisconsin | 427 | 24.3 | 2.9 | (18.6 – 30.0) |
| Puerto Rico | 221 | 43.4 | 4.8 | (34.0 – 52.8) |
| 28 States / Area | 10,336 | 32.7 | 1.1 | (30.5 – 34.9) |
| Median | 32.9 | |||
| Range | 20.3-44.3 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2024/pdf/sdq_report_acbs_24-508.pdf